The DOI matches its Crossref record; 312 of the 314 references it cites were found in a registry or an index.
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Abstract
Mind how you go: The current strategies for the development of therapies for Alzheimer's disease are very diverse. Particular attention is given to the search for inhibitors (see picture for two examples) of the proteolytic enzyme beta- and gamma-secretase, which inhibits the cleavage of the amyloid precursor proteins into amyloid beta peptides, from which the disease-defining deposits of plaque in the brains of Alzheimer's patients originates.Research on senile dementia and Alzheimer's disease covers an extremely broad range of scientific activities. At the recent international meeting of the Alzheimer's Association (ICAD 2008, Chicago) more than 2200 individual scientific contributions were presented. The aim of this Review is to give an overview of the field and to outline its main areas, starting from behavioral abnormalities and visible pathological findings and then focusing on the molecular details of the pathology. The "amyloid hypothesis" of Alzheimer's disease is given particular attention, since the majority of the ongoing therapeutic approaches are based on its theoretical framework.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, use of non-specific chelators (i.e., CQ) that do not interact selectively with the Aβ–metal species exhibit adverse side effects that will likely limit their long term clinical use.3,28,29,31,44,46–48”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [3]
In the citing paper
“as well as lead to formation of reactive oxygen species (ROS) and oxidative stress.3,26–31,33–36”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [3]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Flagged first, then by citations
2 of the 314 references couldn’t be matched to a known paper.
Research works printed but not linked: 11
- Stokin G. B., 2006, J. Physiol., 99, 193
- Younkin S. G., 1986, Fed. Proc., 45, 2982
- Cras P., 1990, Am. J. Pathol., 137, 241
- Yamaguchi H., 1992, Am. J. Pathol., 141, 249
- Tanzi R. E., 2004, Neuron, 43, 605
- Gandy S., 2005, J. Clin. Invest., 115, 1121
- Higgins G. A., 2003, Behav. Pharmacol., 14, 419
- 10.1124/jpet.105.100271 · DOI
- Pissarnitski D., 2007, Curr. Opin. Drug Discovery Dev., 10, 392
- Hills I. D., 2007, Curr. Opin. Drug Discovery Dev., 10, 383
- Durham T. B., 2006, Curr. Opin. Drug Discovery Dev., 9, 776
Cited by
Sorted by citations
Items 401–500 of 663
Tan, M. A., & An, S. S. A. (2020) · 3 Biotech · doi:10.1007/s13205-020-02535-4 · Cited by 17
Liu, J., Liu, Z., Wang, W.-K., & Tian, Y. (2021) · Angewandte Chemie · doi:10.1002/ange.202106193 · Cited by 16
Ghosh, P., Shokeen, K., Mondal, S., Kandasamy, T., Kumar, S., Ghosh, S. S., & Iyer, P. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00473 · Cited by 16
BRI2 and BRI3 are functionally distinct phosphoproteins
Martins, F., Rebelo, S., Santos, M., Cotrim, C. Z., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.012 · Cited by 16
Porter, M. R., Kochi, A., Karty, J. A., Lim, M. H., & Zaleski, J. M. (2014) · Chemical Science · doi:10.1039/c4sc01979b · Cited by 16
Lazzaro, S., Ogrinc, N., Lamont, L., Vecchio, G., Pappalardo, G., & Heeren, R. M. A. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02030-7 · Cited by 16
Xu, Y., & Xiao, L. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00302f · Cited by 16
Histidine Tautomeric Effect on the Key Fragment R3 of Tau Protein from Atomistic Simulations
Li, H., Li, N., Tang, Y., & Lee, J. Y. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00093 · Cited by 16
Chiral effect on Aβ fibrillation from molecular-scale to nanoscale
Gao, G., Zhu, G., Yu, L., Zhang, Z., Zhang, T., Liu, X., Zhang, C., Zhou, L. P., & Sun, T. (2022) · Nano Research · doi:10.1007/s12274-022-4303-9 · Cited by 16
Huang, F., Wang, J., Qu, A., Shen, L., Liu, J., Liu, J., Zhang, Z., An, Y., & Shi, L. (2014) · Angewandte Chemie · doi:10.1002/ange.201400735 · Cited by 16
Yang, S., Zhang, X., Sun, X.-S., Ling, T.-J., Feng, Y., Du, X., Zhao, M., Yang, Y., Xue, D., Wang, L., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100621 · Cited by 16
Rodríguez‐Rodríguez, C., Rimola, A., Alí‐Torres, J., Sodupe, M., & Gonzalez-Duarte, P. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9396-7 · Cited by 16
Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines
Fustero, S., Cuñat, A. C., Flores, S., Báez, C., Oliver–Meseguer, J., Cynamon, M. H., Gütschow, M., Mertens, M. D., Delgado, Ó., Tresadern, G., et al. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102078 · Cited by 16
Medin Oligomer Membrane Pore Formation: A Potential Mechanism of Vascular Dysfunction
Younger, S., Jang, H., Davies, H. A., Niemiec, M., Garcia, J. G. N., Nussinov, R., Migrino, R. Q., Madine, J., & Arce, F. T. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.04.026 · Cited by 16
Terpstra, K., Wang, Y., Huynh, T. T., Bandara, N., Cho, H., Rogers, B. E., & Mirica, L. M. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c02740 · Cited by 16
Hou, T., Shao, X., Ding, M., Mei, K., Wang, X., Guan, P., & Hu, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124432 · Cited by 15
“Common-Precursor” Protein Mimetic Approach to Rescue Aβ Aggregation-Mediated Alzheimer’s Phenotypes
Dohoney, R. A., Joseph, J. A., Baysah, C. Z., Thomas, A. G., Siwakoti, A., Ball, T. D., & Kumar, S. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00120 · Cited by 15
Beck, M. W., Derrick, J. S., Suh, J., Kim, M., Korshavn, K. J., Kerr, R. A., Cho, W. J., Larsen, S. D., Ruotolo, B. T., Ramamoorthy, A., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700456 · Cited by 15
Wang, C.-W., Nan, D., Wang, X.-M., Ke, Z., Chen, G., & Zhou, J. (2017) · 中国科学通报:英文版 · doi:10.1016/j.scib.2017.11.005 · Cited by 16
Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity
Honcharenko, D., Juneja, A., Kurudenkandy, F. R., Maity, J., Galán-Acosta, L., Biverstål, H., Hjorth, E., Johansson, J., Fisahn, A., Nilsson, L., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00485 · Cited by 15
Asili, E., Yarahmadian, S., Khani, H., & Sharify, M. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-019-00583-3 · Cited by 15
Monosialotetrahexosylganglioside Promotes Early Aβ42 Oligomer Formation and Maintenance
Zhang, D. Y., Wang, J., Fleeman, R. M., Kuhn, M. K., Swulius, M. T., Proctor, E. A., & Dokholyan, N. V. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00221 · Cited by 14
Zimbone, S., Giuffrida, M. L., Sabatino, G., Natale, G. D., Tosto, R., Consoli, G. M. L., Milardi, D., Pappalardo, G., & Sciacca, M. F. M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00720 · Cited by 15
Jiang, L., Zhang, M., Tang, L., Weng, Q., Shen, Y., Hu, Y., & Sheng, R. (2016) · RSC Advances · doi:10.1039/c5ra25788c · Cited by 15
Krishnan, H. S., Bernard‐Gauthier, V., Placzek, M. S., Dahl, K., Narayanaswami, V., Livni, E., Chen, Z., Yang, J., Collier, T. L., Ran, C., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00936 · Cited by 15
Basified Human Lysozyme: A Potent Inhibitor against Amyloid β-Protein Fibrillogenesis
Li, X., Xie, B., & Sun, Y. P. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b03278 · Cited by 15
Ma, C., Su, J., Sun, Y., Feng, Y., Shen, N., Li, B., Liang, Y., Yang, X., Wu, H., Zhang, H., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201912399 · Cited by 14
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Nguyen, T. T., Nguyen‐Thi, P., Nguyen, T. H. A., Ho, T.-T., An, T. N. M., Toi, V. V., & Giau, V. V. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00654-1 · Cited by 14
Salvianic borneol ester reduces β-amyloid oligomers and prevents cytotoxicity
Han, M., Liu, Y. M., Zhang, B., Qiao, J., Lu, W., Zhu, Y., Wang, Y., & Zhao, C. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.559585 · Cited by 14
Downey, M. A., Giammona, M. J., Lang, C. A., Buratto, S. K., Singh, A. K., & Bowers, M. T. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-1975-1 · Cited by 15
Park, S., Yi, Y., & Lim, M. H. (2020) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12172 · Cited by 14
Kim, M., & Lim, M. H. (2021) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12372 · Cited by 14
HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24
Hu, L.-T., Xie, X.-Y., Zhou, G.-F., Wen, Q.-X., Song, L., Luo, B., Deng, X.-J., Pan, Q.-L., & Chen, G.-J. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220640 · Cited by 14
Inhibition of γ-secretase by the CK1 inhibitor IC261 does not depend on CK1δ
Höttecke, N., Liebeck, M., Baumann, K., Schubenel, R., Winkler, E., Steiner, H., & Schmidt, B. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.110 · Cited by 14
Wen, G., Chen, D., Qin, W., Zhou, B., Wang, Y., Liu, Z., Du, J., Zhou, Q., Quan, J., & Bu, X. (2017) · Chemical Communications · doi:10.1039/c7cc03102e · Cited by 14
Youssef, K. M., Fawzy, I. M., & El‐Subbagh, H. I. (2017) · Future Journal of Pharmaceutical Sciences · doi:10.1016/j.fjps.2017.06.002 · Cited by 14
Rational design of photoactivatable metal complexes to target and modulate amyloid-β peptides
Kwak, J., Woo, J., Park, S., & Lim, M. H. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112053 · Cited by 13
Aerobic exercise attenuates abnormal myelination and oligodendrocyte differentiation in 3xTg-AD mice
Qiu, D., Zhou, S., Donnelly, J., Xia, D., & Zhao, L. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112293 · Cited by 14
Basutkar, R. S., Sudarsan, P., Robin, S. M., Bhaskar, V., Viswanathan, B., & Ponnusankar, S. (2023) · Neurology India · doi:10.4103/0028-3886.391397 · Cited by 13
Nanoparticle-based Gene Therapy for Neurodegenerative Disorders
Ereej, N., Hameed, H., Khan, M. A., Faheem, S., & Hameed, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575301011240407082559 · Cited by 14
Synthesis of Methoxy-X04 Derivatives and Their Evaluation in Alzheimer's Disease Pathology
Boländer, A., Kieser, D., Scholz, C., Haußen, R. H., Mall, G., Goetschy, V., Czech, C., & Schmidt, B. (2013) · Neurodegenerative Diseases · doi:10.1159/000351436 · Cited by 13
Navarro, S., Čarija, A., Muñoz‐Torrero, D., & Ventura, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.044 · Cited by 13
Roeder, A., Roettger, Y., Stündel, A., Dodel, R. C., & Geyer, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463273 · Cited by 13
Li, M., Zhao, C., Duan, T., Ren, J., & Qu, X. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300470 · Cited by 13
Neuritogenic activity of bi-functional bis-tryptoline triazole
Jiaranaikulwanitch, J., Tadtong, S., Govitrapong, P., Fokin, V. V., & Vajragupta, O. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.027 · Cited by 13
Zhang, F., Yang, W., Sun, R., Duan, X., 杨云华, Wang, A., & Tian, Y. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251401591 · Cited by 13
Novel D–π-A type near-infrared fluorescent probes for the detection of Aβ 40 aggregates
Lv, G., Xu, Y., Yang, J., Li, W., Li, C., & Sun, A. (2020) · The Analyst · doi:10.1039/d0an01180k · Cited by 12
Organoplatinum‐Substituted Polyoxometalate Inhibits β‐amyloid Aggregation for Alzheimer's Therapy
Zhao, J. W., Li, K., Wan, K., Sun, T., Zheng, N., Zhu, F., Ma, J., Jiao, J., Li, T., Ni, J., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201910521 · Cited by 12
Volgraf, M., Chan, L., Huestis, M. P., Purkey, H. E., Burkard, M., Geck, M., Harris, J., Hunt, K. W., Liu, X., Lyssikatos, J. P., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.012 · Cited by 12
Kim, D., Bang, J. K., & Kim, S. H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201410389 · Cited by 12
Lee, H. J., Savelieff, M. G., Kang, J., Brophy, M. B., Nakashige, T. G., Lee, S. J. C., Nolan, E. M., & Lim, M. H. (2018) · Metallomics · doi:10.1039/c8mt00091c · Cited by 12
Xu, S., Sun, Y. P., & Dong, X. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00073 · Cited by 12
Rathnayake, A. U., Abuine, R., Palanisamy, S., Lee, J. K., & Byun, H.-G. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.10.007 · Cited by 11
Xun, Q., Zhang, J., Li, Y.-P., Li, Y., Ma, Y., Chen, Z., Ding, L.-P., & Shi, X.-L. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117236 · Cited by 11
Distinct Aggregation Behavior of N-Terminally Truncated Aβ4–42 Over Aβ1–42 in the Presence of Zn(II)
Na, C., Kim, M., Kim, G., Lin, Y., Lee, Y., Bal, W., Nam, E., & Lim, M. H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00831 · Cited by 11
Assessment of gene order computing methods for Alzheimer's disease
Hu, B.-Q., Jiang, G., Pang, C.-Y., Wang, S., Liu, Q., Chen, Z., Vanderburg, C. R., Rogers, J. T., Deng, Y., & Huang, X. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s8 · Cited by 11
Xu, L., Gao, K., Bao, C., & Wang, X. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9588-4 · Cited by 11
He, H., Xu, J., Li, C., Gao, T., Jiang, P., Jiang, F., & Liu, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100436 · Cited by 11
Lazarova, M. I., Tsvetanova, E. R., Georgieva, A. P., Stefanova, M. O., Uzunova, D. N., Denev, P. N., Vassileva, V., & Tasheva, K. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031840 · Cited by 11
Wang, G., Dai, J., & Lu, X. (2019) · Journal of Cluster Science · doi:10.1007/s10876-019-01735-0 · Cited by 11
Fu, C.-X., Dai, L., Yuan, X.-Y., & Xu, Y. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02280-y · Cited by 11
Tell, V., Mahmoud, K., Wichapong, K., Schächtele, C., Totzke, F., Sippl, W., & Hilgeroth, A. (2012) · MedChemComm · doi:10.1039/c2md20201h · Cited by 11
QSAR Investigation on Quinolizidinyl Derivatives in Alzheimer’s Disease
Ghasemi, G., Arshadi, S., Rashtehroodi, A. N., Nirouei, M., Shariati, S., & Rastgoo, Z. (2013) · Journal of Computational Medicine · doi:10.1155/2013/312728 · Cited by 11
Multitarget-Directed Antioxidants as Therapeutic Agents
Ismaïli, L., Romero, A., Carreiras, M. C., & Marco, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00002-7 · Cited by 11
Akawa, O. B., Subair, T. I., Soremekun, O. S., Olotu, F. A., & Soliman, M. E. S. (2021) · RSC Advances · doi:10.1039/d0ra10459k · Cited by 11
Hu, S., Ning, X., Lv, J., Wei, Y., Zhang, H., & Li, M. C. (2023) · Inorganic Chemistry Frontiers · doi:10.1039/d3qi01079a · Cited by 10
Cu(II) nano-MOF catalyzed synthesis of 4H-Chromene derivatives as cholinesterase inhibitors
Goswami, S., Datta, B., Das, S., Taran, S., Ghosh, P. P., Dasgupta, S., & Ganguly, S. (2024) · Catalysis Today · doi:10.1016/j.cattod.2024.115156 · Cited by 10
Qadir, B. H., Mahmood, M. K., Amin, Y., Kurda, H. A., Rasheed, T. A., Noori, A. H., Noori, Z. F., Abdulghafor, M. A., Fadhil, H. N. M., Fatih, M. T., et al. (2025) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70240 · Cited by 10
Chen, D., Qin, W., Wen, G., Shi, B., Liu, Z., Wang, Y., Zhou, Q., Quan, J., Zhou, B., & Bu, X. (2017) · Chemical Communications · doi:10.1039/c7cc08180d · Cited by 10
Hong, S., Go, Y. K., Derrick, J. S., Han, S., Kim, J., Lim, M. H., & Kim, S. H. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b01824 · Cited by 10
Angelin, M., Larsson, R., Vongvilai, P., & Ramström, O. (2010) · Journal of Chemical Education · doi:10.1021/ed100400v · Cited by 10
The unresolved puzzle why alanine extensions cause disease
Winter, R., Liebold, J., & Schwarz, E. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0112 · Cited by 10
Wang, X., Gill, R. L., Zhu, Q., & Tian, F. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.02.004 · Cited by 10
Activity-based probes as molecular tools for biomarker discovery
Carvalho, L. A. R., Ruivo, E. F. P., Lucas, S. D., & Moreira, R. (2015) · MedChemComm · doi:10.1039/c4md00417e · Cited by 10
Chen, P., Chen, C., Lin, L. T., Lo, C.-H., Hu, C., Chen, R. P. ‐., & Wang, S. S. ‐. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153360 · Cited by 10
Azam, M., Wabaidur, S. M., Haque, M. N., Khan, Z., Al-Resayes, S. I., Al-Foudhily, K. A., Moon, I. S., Trzęsowska‐Kruszyńska, A., & Kruszyński, R. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.03.027 · Cited by 10
Wang, L., Fang, J., Jiang, H., Wang, Q., Xue, S.-T., Li, Z., & Liu, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00334 · Cited by 10
SILVA, D. N. N. D., Mendes, E., Summers, E. J., Neca, A., Jacinto, A. C. C., dos Reis, T. C., Agostinho, P. M., Bolea, I., Jimeno, M. L., Mateus, M. L., et al. (2019) · Drug Development Research · doi:10.1002/ddr.21594 · Cited by 10
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice
Lazarova, M. I., Tancheva, L. P., Tasheva, K. N., Denev, P. N., Uzunova, D. N., Stefanova, M. O., Tsvetanova, E. R., Georgieva, A. P., & Kalfin, R. E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230017 · Cited by 10
Kojima, K., Kitaoka, Y., Munemasa, Y., & Ueno, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10271 · Cited by 10
Meyer, A. G., Bissember, A. C., Hyland, C. J. T., Williams, C. C., Szabó, M., Wales, S. M., Constable, G. E. O., & Olivier, W. J. (2021) · Progress in heterocyclic chemistry · doi:10.1016/b978-0-323-89812-6.00016-x · Cited by 10
Noda, K., Tachi, Y., & Okamoto, Y. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00163 · Cited by 10
ACS Chemical Neuroscience Molecule Spotlight on Semagacestat (LY450139)
Hopkins, C. R. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn1000606 · Cited by 10
Miao, Y., Tang, X. L., & Han, W. (2022) · Chemical Science · doi:10.1039/d1sc06337e · Cited by 9
Song, L., Pan, Q., Zhou, G., Liu, S., Zhu, B., Lin, P., Hu, X., Zha, J., Long, Y., Luo, B., et al. (2024) · Advanced Science · doi:10.1002/advs.202305260 · Cited by 10
Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes
Chen, W., Li, J., Guo, J., Li, L., & Wu, H. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103253 · Cited by 10
Baysah, C. Z., Dohoney, R. A., Palanikumar, L., Stillman, N. H., Penney, A. L., Sola, A. D., Paredes, D., Magzoub, M. M., & Kumar, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00753 · Cited by 9
Tai, L. M., Jacobsen, H., Ozmen, L., Flohr, A., Jakob‐Roetne, R., Caruso, A., & Grimm, H. P. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9246-4 · Cited by 9
Self-citationWang, J., Dong, H., Leng, T., Yu, Y., & Li, Y. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp04278e · Cited by 9
Wu, T., Zhang, Y., Li, H., Pan, Z., Ding, J., Zhang, W., Cai, S., & Yang, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136501 · Cited by 8
Simple approach to the synthesis of novel tricyclic BACE1 inhibitor warhead through β-lactam opening
Abed, H. B., Brandt, S. F. A. V., Vega, J. A., & Gijsen, H. J. M. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.05.017 · Cited by 9
Guo, L., & Sun, B. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00574 · Cited by 9
Maity, D., Oh, Y., Gremer, L., Hoyer, W., Magzoub, M. M., & Hamilton, A. D. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202200456 · Cited by 9
Xu, L., Wang, X., & Wang, X. (2013) · European Biophysics Journal · doi:10.1007/s00249-013-0906-0 · Cited by 11
Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases
Nguyen‐Thi, P., Ho, T.-T., Nguyen, T. T., & Vo, G. V. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230707113405 · Cited by 8
Zhang, M., Tang, L., Jiang, L., Wei, J., Hu, Y., & Sheng, R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113096 · Cited by 8
Ranade, D. S., Shravage, B. V., Kumbhar, A. A., Sonavane, U., Jani, V., Joshi, R., & Kulkarni, P. P. (2017) · ChemistrySelect · doi:10.1002/slct.201700588 · Cited by 8
Smith, J. A., Molesworth, P. P., Hyland, C. J. T., & Ryan, J. H. (2010) · Progress in heterocyclic chemistry · doi:10.1016/s0959-6380(11)22016-6 · Cited by 8
Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases
Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8
ACS Chemical Neuroscience Molecule Spotlight on BMS-708163
Hopkins, C. R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000179 · Cited by 8
Metadata
- Authors
- Jakob‐Roetne, R., & Jacobsen, H.
- Affiliations
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Jakob‐Roetne, Roland
- Jacobsen, Helmut
- ORCID
- Jacobsen, Helmut
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2009-04-07
- Volume
- 48
- Issue
- 17
- Pages
- 3030-3059
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2065100984
- Cited by
- 626
- References
- 314
- Citations by year
- 2026: 21 · 2025: 19 · 2024: 27 · 2023: 26 · 2022: 39 · 2021: 27 · 2020: 38 · 2019: 37 · 2018: 39 · 2017: 49 · 2016: 40 · 2015: 52 · 2014: 45 · 2013: 45 · 2012: 43
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid hypothesis, beta-secretase inhibitors, gamma-secretase inhibitors, amyloid precursor protein, amyloid-beta, amyloid plaques, behavioral abnormalities, Alzheimer's disease pathology, Alzheimer's disease therapeutics
- MeSH terms
- Alzheimer Disease, Amyloid, Humans, Protease Inhibitors, Amyloid Precursor Protein Secretases, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review